{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T15:12:18Z","timestamp":1768403538396,"version":"3.49.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,27]],"date-time":"2019-12-27T00:00:00Z","timestamp":1577404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,12,27]],"date-time":"2019-12-27T00:00:00Z","timestamp":1577404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Aberrant expression of the Spectraplakin Dystonin (DST) has been observed in various cancers, including those of the breast. However, little is known about its role in carcinogenesis. In this report, we demonstrate that Dystonin is a candidate tumour suppressor in breast cancer and provide an underlying molecular mechanism. We show that in MCF10A cells, Dystonin is necessary to restrain cell growth, anchorage-independent growth, self-renewal properties and resistance to doxorubicin. Strikingly, while Dystonin maintains focal adhesion integrity, promotes cell spreading and cell-substratum adhesion, it prevents Zyxin accumulation, stabilizes LATS and restricts YAP activation. Moreover, treating DST-depleted MCF10A cells with the YAP inhibitor Verteporfin prevents their growth. <jats:italic>In vivo<\/jats:italic>, the <jats:italic>Drosophila<\/jats:italic> Dystonin Short stop also restricts tissue growth by limiting Yorkie activity. As the two Dystonin isoforms BPAG1eA and BPAG1e are necessary to inhibit the acquisition of transformed features and are both downregulated in breast tumour samples and in MCF10A cells with conditional induction of the Src proto-oncogene, they could function as the predominant Dystonin tumour suppressor variants in breast epithelial cells. Thus, their loss could deem as promising prognostic biomarkers for breast cancer.<\/jats:p>","DOI":"10.1038\/s41598-019-56296-z","type":"journal-article","created":{"date-parts":[[2019,12,27]],"date-time":"2019-12-27T11:03:12Z","timestamp":1577444592000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["The spectraplakin Dystonin antagonizes YAP activity and suppresses tumourigenesis"],"prefix":"10.1038","volume":"9","author":[{"given":"Praachi B.","family":"Jain","sequence":"first","affiliation":[]},{"given":"Patr\u00edcia S.","family":"Guerreiro","sequence":"additional","affiliation":[]},{"given":"Sara","family":"Canato","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4326-0163","authenticated-orcid":false,"given":"Florence","family":"Janody","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2019,12,27]]},"reference":[{"key":"56296_CR1","first-page":"13","volume":"34","author":"D Martins","year":"2019","unstructured":"Martins, D. & Schmitt, F. Microenvironment in breast tumorigenesis: Friend or foe? Histol. Histopathol. 34, 13\u201324 (2019).","journal-title":"Histol. Histopathol."},{"key":"56296_CR2","first-page":"1071","volume":"34","author":"S Byler","year":"2014","unstructured":"Byler, S. et al. Genetic and epigenetic aspects of breast cancer progression and therapy. Anticancer Res. 34, 1071\u20137 (2014).","journal-title":"Anticancer Res."},{"key":"56296_CR3","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.7150\/jca.13141","volume":"7","author":"X Dai","year":"2016","unstructured":"Dai, X., Xiang, L., Li, T. & Bai, Z. Cancer Hallmarks, Biomarkers and Breast Cancer Molecular Subtypes. J. Cancer 7, 1281\u20131294 (2016).","journal-title":"J. Cancer"},{"key":"56296_CR4","doi-asserted-by":"publisher","first-page":"a006098","DOI":"10.1101\/cshperspect.a006098","volume":"5","author":"R Sever","year":"2015","unstructured":"Sever, R. & Brugge, J. S. Signal transduction in cancer. Cold Spring Harb. Perspect. Med. 5, a006098\u2013a006098 (2015).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"56296_CR5","doi-asserted-by":"crossref","unstructured":"Wu, L. & Yang, X. Targeting the Hippo Pathway for Breast Cancer Therapy. Cancers (Basel). 10 (2018).","DOI":"10.3390\/cancers10110422"},{"key":"56296_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/gad.274027.115","volume":"30","author":"Z Meng","year":"2016","unstructured":"Meng, Z., Moroishi, T. & Guan, K.-L. Mechanisms of Hippo pathway regulation. Genes Dev. 30, 1\u201317 (2016).","journal-title":"Genes Dev."},{"key":"56296_CR7","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1038\/sj.onc.1208445","volume":"24","author":"EHY Chan","year":"2005","unstructured":"Chan, E. H. Y. et al. The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1. Oncogene 24, 2076\u20132086 (2005).","journal-title":"Oncogene"},{"key":"56296_CR8","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1016\/j.cub.2018.04.018","volume":"28","author":"SA Manning","year":"2018","unstructured":"Manning, S. A. et al. Dynamic Fluctuations in Subcellular Localization of the Hippo Pathway Effector Yorkie In Vivo. Curr. Biol. 28, 1651\u20131660.e4 (2018).","journal-title":"Curr. Biol."},{"key":"56296_CR9","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.cell.2005.06.007","volume":"122","author":"J Huang","year":"2005","unstructured":"Huang, J., Wu, S., Barrera, J., Matthews, K. & Pan, D. The Hippo Signaling Pathway Coordinately Regulates Cell Proliferation and Apoptosis by Inactivating Yorkie, the Drosophila Homolog of YAP. Cell 122, 421\u2013434 (2005).","journal-title":"Cell"},{"key":"56296_CR10","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1101\/gad.1602907","volume":"21","author":"B Zhao","year":"2007","unstructured":"Zhao, B. et al. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev. 21, 2747\u20132761 (2007).","journal-title":"Genes Dev."},{"key":"56296_CR11","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1128\/MCB.01874-07","volume":"28","author":"Q-Y Lei","year":"2008","unstructured":"Lei, Q.-Y. et al. TAZ Promotes Cell Proliferation and Epithelial-Mesenchymal Transition and Is Inhibited by the Hippo Pathway. Mol. Cell. Biol. 28, 2426\u20132436 (2008).","journal-title":"Mol. Cell. Biol."},{"key":"56296_CR12","doi-asserted-by":"publisher","first-page":"5496","DOI":"10.1074\/jbc.M709037200","volume":"283","author":"Y Hao","year":"2008","unstructured":"Hao, Y., Chun, A., Cheung, K., Rashidi, B. & Yang, X. Tumor Suppressor LATS1 Is a Negative Regulator of Oncogene YAP. J. Biol. Chem. 283, 5496\u20135509 (2008).","journal-title":"J. Biol. Chem."},{"key":"56296_CR13","doi-asserted-by":"publisher","first-page":"37159","DOI":"10.1074\/jbc.M110.152942","volume":"285","author":"C-Y Liu","year":"2010","unstructured":"Liu, C.-Y. et al. The Hippo Tumor Pathway Promotes TAZ Degradation by Phosphorylating a Phosphodegron and Recruiting the SCF\u03b2-TrCP E3 Ligase. J. Biol. Chem. 285, 37159\u201337169 (2010).","journal-title":"J. Biol. Chem."},{"key":"56296_CR14","doi-asserted-by":"publisher","first-page":"27534","DOI":"10.1074\/jbc.M804380200","volume":"283","author":"T Oka","year":"2008","unstructured":"Oka, T., Mazack, V. & Sudol, M. Mst2 and Lats Kinases Regulate Apoptotic Function of Yes Kinase-associated Protein (YAP). J. Biol. Chem. 283, 27534\u201327546 (2008).","journal-title":"J. Biol. Chem."},{"key":"56296_CR15","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1101\/gad.1843810","volume":"24","author":"B Zhao","year":"2010","unstructured":"Zhao, B., Li, L., Tumaneng, K., Wang, C.-Y. & Guan, K.-L. A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF -TRCP. Genes Dev. 24, 72\u201385 (2010).","journal-title":"Genes Dev."},{"key":"56296_CR16","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1101\/gad.888601","volume":"15","author":"A Vassilev","year":"2001","unstructured":"Vassilev, A., Kaneko, K. J., Shu, H., Zhao, Y. & DePamphilis, M. L. TEAD\/TEF transcription factors utilize the activation domain of YAP65, a Src\/Yes-associated protein localized in the cytoplasm. Genes Dev. 15, 1229\u20131241 (2001).","journal-title":"Genes Dev."},{"key":"56296_CR17","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1101\/gad.1664408","volume":"22","author":"B Zhao","year":"2008","unstructured":"Zhao, B. et al. TEAD mediates YAP-dependent gene induction and growth control. Genes Dev. 22, 1962\u20131971 (2008).","journal-title":"Genes Dev."},{"key":"56296_CR18","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.devcel.2008.01.007","volume":"14","author":"S Wu","year":"2008","unstructured":"Wu, S., Liu, Y., Zheng, Y., Dong, J. & Pan, D. The TEAD\/TEF Family Protein Scalloped Mediates Transcriptional Output of the Hippo Growth-Regulatory Pathway. Dev. Cell 14, 388\u2013398 (2008).","journal-title":"Dev. Cell"},{"key":"56296_CR19","doi-asserted-by":"publisher","first-page":"4059","DOI":"10.1242\/dev.027151","volume":"135","author":"M Ota","year":"2008","unstructured":"Ota, M. & Sasaki, H. Mammalian Tead proteins regulate cell proliferation and contact inhibition as transcriptional mediators of Hippo signaling. Development 135, 4059\u20134069 (2008).","journal-title":"Development"},{"key":"56296_CR20","doi-asserted-by":"publisher","first-page":"14347","DOI":"10.1074\/jbc.M901568200","volume":"284","author":"SW Chan","year":"2009","unstructured":"Chan, S. W. et al. TEADs Mediate Nuclear Retention of TAZ to Promote Oncogenic Transformation. J. Biol. Chem. 284, 14347\u201314358 (2009).","journal-title":"J. Biol. Chem."},{"key":"56296_CR21","doi-asserted-by":"publisher","first-page":"13355","DOI":"10.1074\/jbc.M900843200","volume":"284","author":"H Zhang","year":"2009","unstructured":"Zhang, H. et al. TEAD Transcription Factors Mediate the Function of TAZ in Cell Growth and Epithelial-Mesenchymal Transition. J. Biol. Chem. 284, 13355\u201313362 (2009).","journal-title":"J. Biol. Chem."},{"key":"56296_CR22","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.cell.2013.07.042","volume":"154","author":"M Aragona","year":"2013","unstructured":"Aragona, M. et al. A Mechanical Checkpoint Controls Multicellular Growth through YAP\/TAZ Regulation by Actin-Processing Factors. Cell 154, 1047\u20131059 (2013).","journal-title":"Cell"},{"key":"56296_CR23","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nature10137","volume":"474","author":"S Dupont","year":"2011","unstructured":"Dupont, S. et al. Role of YAP\/TAZ in mechanotransduction. Nature 474, 179\u2013183 (2011).","journal-title":"Nature"},{"key":"56296_CR24","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1242\/dev.063545","volume":"138","author":"BG Fernandez","year":"2011","unstructured":"Fernandez, B. G. et al. Actin-Capping Protein and the Hippo pathway regulate F-actin and tissue growth in Drosophila. Development 138, 2337\u20132346 (2011).","journal-title":"Development"},{"key":"56296_CR25","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1038\/emboj.2011.157","volume":"30","author":"L Sansores-Garcia","year":"2011","unstructured":"Sansores-Garcia, L. et al. Modulating F-actin organization induces organ growth by affecting the Hippo pathway. EMBO J. 30, 2325\u20132335 (2011).","journal-title":"EMBO J."},{"key":"56296_CR26","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.cub.2015.01.010","volume":"25","author":"P Gaspar","year":"2015","unstructured":"Gaspar, P., Holder, M. V., Aerne, B. L., Janody, F. & Tapon, N. Zyxin Antagonizes the FERM Protein Expanded to Couple F-Actin and Yorkie-Dependent Organ Growth. Curr. Biol. 25, 679\u2013689 (2015).","journal-title":"Curr. Biol."},{"key":"56296_CR27","doi-asserted-by":"publisher","first-page":"e1000624","DOI":"10.1371\/journal.pbio.1000624","volume":"9","author":"C Rauskolb","year":"2011","unstructured":"Rauskolb, C., Pan, G., Reddy, B. V. V. G., Oh, H. & Irvine, K. D. Zyxin Links Fat Signaling to the Hippo Pathway. PLoS Biol. 9, e1000624 (2011).","journal-title":"PLoS Biol."},{"key":"56296_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11123","volume":"7","author":"B Ma","year":"2016","unstructured":"Ma, B. et al. Zyxin-Siah2-Lats2 axis mediates cooperation between Hippo and TGF-\u03b2 signalling pathways. Nat. Commun. 7, 11123 (2016).","journal-title":"Nat. Commun."},{"key":"56296_CR29","unstructured":"Alberts, B. A. et al. Molecular Biology of the Cell (6th Edition). In (Garland Science, 2014)."},{"key":"56296_CR30","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1242\/jcs.196154","volume":"130","author":"J Zhang","year":"2017","unstructured":"Zhang, J., Yue, J. & Wu, X. Spectraplakin family proteins - cytoskeletal crosslinkers with versatile roles. J. Cell Sci. 130, 2447\u20132457 (2017).","journal-title":"J. Cell Sci."},{"key":"56296_CR31","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.semcdb.2017.05.019","volume":"69","author":"A Voelzmann","year":"2017","unstructured":"Voelzmann, A. et al. Drosophila Short stop as a paradigm for the role and regulation of spectraplakins. Semin. Cell Dev. Biol. 69, 40\u201357 (2017).","journal-title":"Semin. Cell Dev. Biol."},{"key":"56296_CR32","doi-asserted-by":"publisher","first-page":"368","DOI":"10.3390\/ijms19020368","volume":"19","author":"QA Quick","year":"2018","unstructured":"Quick, Q. A. Microtubule-Actin Crosslinking Factor 1 and Plakins as Therapeutic Drug Targets. Int. J. Mol. Sci. 19, 368 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"56296_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15237","volume":"8","author":"S Tavares","year":"2017","unstructured":"Tavares, S. et al. Actin stress fiber organization promotes cell stiffening and proliferation of pre-invasive breast cancer cells. Nat. Commun. 8, 15237 (2017).","journal-title":"Nat. Commun."},{"key":"56296_CR34","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.ccr.2010.01.022","volume":"17","author":"HA Hirsch","year":"2010","unstructured":"Hirsch, H. A. et al. A Transcriptional Signature and Common Gene Networks Link Cancer with Lipid Metabolism and Diverse Human Diseases. Cancer Cell 17, 348\u2013361 (2010).","journal-title":"Cancer Cell"},{"key":"56296_CR35","doi-asserted-by":"publisher","first-page":"4574","DOI":"10.1158\/0008-5472.CAN-12-0636","volume":"72","author":"S Lee","year":"2012","unstructured":"Lee, S. et al. Differentially Expressed Genes Regulating the Progression of Ductal Carcinoma In Situ to Invasive Breast Cancer. Cancer Res. 72, 4574\u20134586 (2012).","journal-title":"Cancer Res."},{"key":"56296_CR36","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s004410100462","volume":"306","author":"C Herold-Mende","year":"2001","unstructured":"Herold-Mende, C., Kartenbeck, J., Tomakidi, P. & Bosch, F. X. Metastatic growth of squamous cell carcinomas is correlated with upregulation and redistribution of hemidesmosomal components. Cell Tissue Res. 306, 399\u2013408 (2001).","journal-title":"Cell Tissue Res."},{"key":"56296_CR37","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.yexcr.2017.08.034","volume":"360","author":"PR Chaudhari","year":"2017","unstructured":"Chaudhari, P. R., Charles, S. E., D\u2019Souza, Z. C. & Vaidya, M. M. Hemidesmosomal linker proteins regulate cell motility, invasion and tumorigenicity in oral squamous cell carcinoma derived cells. Exp. Cell Res. 360, 125\u2013137 (2017).","journal-title":"Exp. Cell Res."},{"key":"56296_CR38","doi-asserted-by":"publisher","first-page":"7507","DOI":"10.1158\/0008-5472.CAN-09-2994","volume":"69","author":"HA Hirsch","year":"2009","unstructured":"Hirsch, H. A., Iliopoulos, D., Tsichlis, P. N. & Struhl, K. Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission. Cancer Res. 69, 7507\u20137511 (2009).","journal-title":"Cancer Res."},{"key":"56296_CR39","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cell.2009.10.014","volume":"139","author":"D Iliopoulos","year":"2009","unstructured":"Iliopoulos, D., Hirsch, H. A. & Struhl, K. An Epigenetic Switch Involving NF-\u03baB, Lin28, Let-7 MicroRNA, and IL6 Links Inflammation to Cell Transformation. Cell 139, 693\u2013706 (2009).","journal-title":"Cell"},{"key":"56296_CR40","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1038\/nmeth.2598","volume":"10","author":"ML Maeder","year":"2013","unstructured":"Maeder, M. L. et al. CRISPR RNA\u2013guided activation of endogenous human genes. Nat. Methods 10, 977\u2013979 (2013).","journal-title":"Nat. Methods"},{"key":"56296_CR41","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.pharmthera.2013.10.001","volume":"141","author":"C Neuzillet","year":"2014","unstructured":"Neuzillet, C. et al. MEK in cancer and cancer therapy. Pharmacol. Ther. 141, 160\u2013171 (2014).","journal-title":"Pharmacol. Ther."},{"key":"56296_CR42","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1002\/bies.950191104","volume":"19","author":"MC Beckerle","year":"1997","unstructured":"Beckerle, M. C. Zyxin: Zinc fingers at sites of cell adhesion. BioEssays 19, 949\u2013957 (1997).","journal-title":"BioEssays"},{"key":"56296_CR43","doi-asserted-by":"publisher","first-page":"7928","DOI":"10.1038\/sj.onc.1208080","volume":"23","author":"MP Playford","year":"2004","unstructured":"Playford, M. P. & Schaller, M. D. The interplay between Src and integrins in normal and tumor biology. Oncogene 23, 7928\u20137946 (2004).","journal-title":"Oncogene"},{"key":"56296_CR44","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1042\/BJ20041434","volume":"388","author":"WM Mahoney","year":"2005","unstructured":"Mahoney, W. M., Hong, J.-H., Yaffe, M. B. & Farrance, I. K. G. The transcriptional co-activator TAZ interacts differentially with transcriptional enhancer factor-1 (TEF-1) family members. Biochem. J. 388, 217\u201325 (2005).","journal-title":"Biochem. J."},{"key":"56296_CR45","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.exer.2014.04.011","volume":"124","author":"K Brodowska","year":"2014","unstructured":"Brodowska, K. et al. The clinically used photosensitizer Verteporfin (VP) inhibits YAP-TEAD and human retinoblastoma cell growth in vitro without light activation. Exp. Eye Res. 124, 67\u201373 (2014).","journal-title":"Exp. Eye Res."},{"key":"56296_CR46","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/bs.mie.2015.06.022","volume":"569","author":"I Hahn","year":"2016","unstructured":"Hahn, I., Ronshaugen, M., S\u00e1nchez-Soriano, N. & Prokop, A. Functional and Genetic Analysis of Spectraplakins in Drosophila. Methods Enzymol. 569, 373\u2013405 (2016).","journal-title":"Methods Enzymol."},{"key":"56296_CR47","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1242\/jcs.041806","volume":"122","author":"A Genevet","year":"2009","unstructured":"Genevet, A. et al. The Hippo pathway regulates apical-domain size independently of its growth-control function. J. Cell Sci. 122, 2360\u20132370 (2009).","journal-title":"J. Cell Sci."},{"key":"56296_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-016-2852-6","volume":"17","author":"IS Yang","year":"2016","unstructured":"Yang, I. S., Son, H., Kim, S. & Kim, S. ISOexpresso: a web-based platform for isoform-level expression analysis in human cancer. BMC Genomics 17, 631 (2016).","journal-title":"BMC Genomics"},{"key":"56296_CR49","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/nrd4161","volume":"13","author":"R Johnson","year":"2014","unstructured":"Johnson, R. & Halder, G. The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment. Nat. Rev. Drug Discov. 13, 63\u201379 (2014).","journal-title":"Nat. Rev. Drug Discov."},{"key":"56296_CR50","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1083\/jcb.201501025","volume":"210","author":"N-G Kim","year":"2015","unstructured":"Kim, N.-G. & Gumbiner, B. M. Adhesion to fibronectin regulates Hippo signaling via the FAK-Src-PI3K pathway. J. Cell Biol. 210, 503\u201315 (2015).","journal-title":"J. Cell Biol."},{"key":"56296_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15321","volume":"8","author":"G Nardone","year":"2017","unstructured":"Nardone, G. et al. YAP regulates cell mechanics by controlling focal adhesion assembly. Nat. Commun. 8, 15321 (2017).","journal-title":"Nat. Commun."},{"key":"56296_CR52","doi-asserted-by":"crossref","unstructured":"Hamill, K. J., Hopkinson, S. B., DeBiase, P. & Jones, J. C. R. BPAG1e maintains keratinocyte polarity through beta4 integrin-mediated modulation of Rac1 and cofilin activities. Mol. Biol. Cell 20, 2954\u201362 (2009).","DOI":"10.1091\/mbc.e09-01-0051"},{"key":"56296_CR53","doi-asserted-by":"publisher","first-page":"339","DOI":"10.5604\/01.3001.0010.3818","volume":"71","author":"Z Ostrowska","year":"2017","unstructured":"Ostrowska, Z. & Moraczewska, J. Cofilin - a protein controlling dynamics of actin filaments. Postepy Hig. Med. Dosw. (Online) 71, 339\u2013351 (2017).","journal-title":"Postepy Hig. Med. Dosw. (Online)"},{"key":"56296_CR54","doi-asserted-by":"publisher","first-page":"5144","DOI":"10.1038\/onc.2016.46","volume":"35","author":"C Ko","year":"2016","unstructured":"Ko, C., Kim, Y.-G., Le, T. P. & Choi, K.-W. Twinstar\/cofilin is required for regulation of epithelial integrity and tissue growth in Drosophila. Oncogene 35, 5144\u20135154 (2016).","journal-title":"Oncogene"},{"key":"56296_CR55","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1091\/mbc.e13-10-0609","volume":"25","author":"A Aguilar","year":"2014","unstructured":"Aguilar, A. et al. \u0391-tubulin K40 acetylation is required for contact inhibition of proliferation and cell-substrate adhesion. Mol. Biol. Cell 25, 1854\u201366 (2014).","journal-title":"Mol. Biol. Cell"},{"key":"56296_CR56","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.devcel.2011.08.028","volume":"21","author":"JC Boggiano","year":"2011","unstructured":"Boggiano, J. C., Vanderzalm, P. J. & Fehon, R. G. Tao-1 Phosphorylates Hippo\/MST Kinases to Regulate the Hippo-Salvador-Warts Tumor Suppressor Pathway. Dev. Cell 21, 888\u2013895 (2011).","journal-title":"Dev. Cell"},{"key":"56296_CR57","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.devcel.2011.09.012","volume":"21","author":"CLC Poon","year":"2011","unstructured":"Poon, C. L. C., Lin, J. I., Zhang, X. & Harvey, K. F. The Sterile 20-like Kinase Tao-1 Controls Tissue Growth by Regulating the Salvador-Warts-Hippo Pathway. Dev. Cell 21, 896\u2013906 (2011).","journal-title":"Dev. Cell"},{"key":"56296_CR58","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1083\/jcb.142.1.271","volume":"142","author":"RQ Schaapveld","year":"1998","unstructured":"Schaapveld, R. Q. et al. Hemidesmosome formation is initiated by the beta4 integrin subunit, requires complex formation of beta4 and HD1\/plectin, and involves a direct interaction between beta4 and the bullous pemphigoid antigen 180. J. Cell Biol. 142, 271\u201384 (1998).","journal-title":"J. Cell Biol."},{"key":"56296_CR59","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1006\/excr.1997.3923","volume":"239","author":"L Borradori","year":"1998","unstructured":"Borradori, L. et al. Role of the bullous pemphigoid antigen 180 (BP180) in the assembly of hemidesmosomes and cell adhesion\u2013reexpression of BP180 in generalized atrophic benign epidermolysis bullosa keratinocytes. Exp. Cell Res. 239, 463\u201376 (1998).","journal-title":"Exp. Cell Res."},{"key":"56296_CR60","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1091\/mbc.11.1.277","volume":"11","author":"SB Hopkinson","year":"2000","unstructured":"Hopkinson, S. B. & Jones, J. C. The N terminus of the transmembrane protein BP180 interacts with the N-terminal domain of BP230, thereby mediating keratin cytoskeleton anchorage to the cell surface at the site of the hemidesmosome. Mol. Biol. Cell 11, 277\u201386 (2000).","journal-title":"Mol. Biol. Cell"},{"key":"56296_CR61","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1242\/jcs.00241","volume":"116","author":"J Koster","year":"2003","unstructured":"Koster, J., Geerts, D., Favre, B., Borradori, L. & Sonnenberg, A. Analysis of the interactions between BP180, BP230, plectin and the integrin alpha6beta4 important for hemidesmosome assembly. J. Cell Sci. 116, 387\u201399 (2003).","journal-title":"J. Cell Sci."},{"key":"56296_CR62","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1038\/jid.2010.19","volume":"130","author":"RW Groves","year":"2010","unstructured":"Groves, R. W. et al. A homozygous nonsense mutation within the dystonin gene coding for the coiled-coil domain of the epithelial isoform of BPAG1 underlies a new subtype of autosomal recessive epidermolysis bullosa simplex. J. Invest. Dermatol. 130, 1551\u20137 (2010).","journal-title":"J. Invest. Dermatol."},{"key":"56296_CR63","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1038\/jid.2011.379","volume":"132","author":"L Liu","year":"2012","unstructured":"Liu, L. et al. Autosomal recessive epidermolysis bullosa simplex due to loss of BPAG1-e expression. J. Invest. Dermatol. 132, 742\u20134 (2012).","journal-title":"J. Invest. Dermatol."},{"key":"56296_CR64","first-page":"1823","volume":"147","author":"LM Bergstraesser","year":"1995","unstructured":"Bergstraesser, L. M., Srinivasan, G., Jones, J. C., Stahl, S. & Weitzman, S. A. Expression of hemidesmosomes and component proteins is lost by invasive breast cancer cells. Am. J. Pathol. 147, 1823\u201339 (1995).","journal-title":"Am. J. Pathol."},{"key":"56296_CR65","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1038\/jid.2009.439","volume":"130","author":"T Ozawa","year":"2010","unstructured":"Ozawa, T. et al. Dynamic relationship of focal contacts and hemidesmosome protein complexes in live cells. J. Invest. Dermatol. 130, 1624\u201335 (2010).","journal-title":"J. Invest. Dermatol."},{"key":"56296_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10186","volume":"6","author":"T Kim","year":"2015","unstructured":"Kim, T. et al. A basal-like breast cancer-specific role for SRF-IL6 in YAP-induced cancer stemness. Nat. Commun. 6, 10186 (2015).","journal-title":"Nat. Commun."},{"key":"56296_CR67","doi-asserted-by":"publisher","first-page":"e201800171","DOI":"10.26508\/lsa.201800171","volume":"1","author":"N Furth","year":"2018","unstructured":"Furth, N. et al. LATS1 and LATS2 suppress breast cancer progression by maintaining cell identity and metabolic state. Life Sci. Alliance 1, e201800171 (2018).","journal-title":"Life Sci. Alliance"},{"key":"56296_CR68","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.ejca.2011.10.001","volume":"48","author":"X Wang","year":"2012","unstructured":"Wang, X., Su, L. & Ou, Q. Yes-associated protein promotes tumour development in luminal epithelial derived breast cancer. Eur. J. Cancer 48, 1227\u201334 (2012).","journal-title":"Eur. J. Cancer"},{"key":"56296_CR69","doi-asserted-by":"publisher","first-page":"12405","DOI":"10.1073\/pnas.0605579103","volume":"103","author":"M Overholtzer","year":"2006","unstructured":"Overholtzer, M. et al. Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon. Proc. Natl. Acad. Sci. 103, 12405\u201312410 (2006).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"56296_CR70","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1016\/j.ajpath.2012.02.025","volume":"180","author":"X Zhi","year":"2012","unstructured":"Zhi, X., Zhao, D., Zhou, Z., Liu, R. & Chen, C. YAP Promotes Breast Cell Proliferation and Survival Partially through Stabilizing the KLF5 Transcription Factor. Am. J. Pathol. 180, 2452\u20132461 (2012).","journal-title":"Am. J. Pathol."},{"key":"56296_CR71","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0304-3835(00)00683-2","volume":"163","author":"AK Lo","year":"2001","unstructured":"Lo, A. K. et al. Downregulation of hemidesmosomal proteins in nasopharyngeal carcinoma cells. Cancer Lett. 163, 117\u201323 (2001).","journal-title":"Cancer Lett."},{"key":"56296_CR72","doi-asserted-by":"publisher","first-page":"e00695","DOI":"10.1016\/j.heliyon.2018.e00695","volume":"4","author":"A Kotb","year":"2018","unstructured":"Kotb, A., Hyndman, M. E. & Patel, T. R. The role of zyxin in regulation of malignancies. Heliyon 4, e00695 (2018).","journal-title":"Heliyon"},{"key":"56296_CR73","doi-asserted-by":"publisher","first-page":"498","DOI":"10.4161\/cc.8.3.7701","volume":"8","author":"D Wiederschain","year":"2009","unstructured":"Wiederschain, D. et al. Single-vector inducible lentiviral RNAi system for oncology target validation. Cell Cycle 8, 498\u2013504 (2009).","journal-title":"Cell Cycle"},{"key":"56296_CR74","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/nprot.2008.73","volume":"3","author":"TD Schmittgen","year":"2008","unstructured":"Schmittgen, T. D. & Livak, K. J. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 3, 1101\u20138 (2008).","journal-title":"Nat. Protoc."},{"key":"56296_CR75","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1126\/science.274.5285.252","volume":"274","author":"M Calleja","year":"1996","unstructured":"Calleja, M., Moreno, E., Pelaz, S. & Morata, G. Visualization of gene expression in living adult Drosophila. Science 274, 252\u20135 (1996).","journal-title":"Science"},{"key":"56296_CR76","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.cell.2004.12.036","volume":"120","author":"Z-C Lai","year":"2005","unstructured":"Lai, Z.-C. et al. Control of Cell Proliferation and Apoptosis by Mob as Tumor Suppressor, Mats. Cell 120, 675\u2013685 (2005).","journal-title":"Cell"},{"key":"56296_CR77","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1242\/dev.00159","volume":"129","author":"S Lee","year":"2002","unstructured":"Lee, S. & Kolodziej, P. A. The plakin Short Stop and the RhoA GTPase are required for E-cadherin-dependent apical surface remodeling during tracheal tube fusion. Development 129, 1509\u201320 (2002).","journal-title":"Development"},{"key":"56296_CR78","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/genetics\/153.1.135","volume":"153","author":"AC Spradling","year":"1999","unstructured":"Spradling, A. C. et al. The Berkeley Drosophila Genome Project gene disruption project: Single P-element insertions mutating 25% of vital Drosophila genes. Genetics 153, 135\u201377 (1999).","journal-title":"Genetics"},{"key":"56296_CR79","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1038\/nprot.2006.339","volume":"1","author":"NAP Franken","year":"2006","unstructured":"Franken, N. A. P., Rodermond, H. M., Stap, J., Haveman, J. & van Bree, C. Clonogenic assay of cells in vitro. Nat. Protoc. 1, 2315\u20132319 (2006).","journal-title":"Nat. Protoc."},{"key":"56296_CR80","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1158\/1541-7786.MCR-09-0207","volume":"7","author":"B Hu","year":"2009","unstructured":"Hu, B., Thirtamara-Rajamani, K. K., Sim, H. & Viapiano, M. S. Fibulin-3 Is Uniquely Upregulated in Malignant Gliomas and Promotes Tumor Cell Motility and Invasion. Mol. Cancer Res. 7, 1756\u20131770 (2009).","journal-title":"Mol. Cancer Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-56296-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-56296-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-56296-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T17:57:06Z","timestamp":1671299826000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-56296-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,27]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["56296"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-56296-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,27]]},"assertion":[{"value":"25 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors of this manuscript declare that they have no conflict of interest and no competing financial interests in relation to the work described. The material of this work is original research, has not been previously published and has not been submitted for publication elsewhere while under consideration.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19843"}}